Skip to content

Efinaconazole

    Brands

    DEA Class; Rx

    Common Brand Names; Jublia

    • Antifungals, Topical

    Topical azole antifungal solution
    Used for the treatment of onychomycosis of the toenails in adults and pediatric patients 6 years and older
    Onychocryptosis (ingrown toenail) was the most frequently reported adverse event during clinical trials

    Indicated for onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes

    —

    Ingrown toenail (2.3%)

    Application site dermatitis (2.2%)

    Application site vesicles (1.6%)

    Application site pain (1.1%)

    For topical use only

    Not for oral, ophthalmic, or intravaginal use

    Instruct patient to avoid using nail polish or cosmetic nail products

    Persistent local pain, irritation, or dermatitis may develop; contact health provider if it occurs

    Data are not available for use during pregnancy to inform any drug associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes

    Unknown if excreted in human milk

    Adults

    Specific maximum dosage information not available.

    Geriatric

    Specific maximum dosage information not available.

    Adolescents

    Specific maximum dosage information not available.

    Children

    6 to 12 years: Specific maximum dosage information not available.
    1 to 5 years: Safety and efficacy have not been established.

    Infants

    Safety and efficacy have not been established.

    Neonates

    Safety and efficacy have not been established.

    Efinaconazole

    topical solution

    • 10%